Download
13023_2024_Article_3118.pdf 897,79KB
WeightNameValue
1000 Titel
  • Patients’ and physicians’ awareness of clinical symptoms and disease severity in tuberous sclerosis complex
1000 Autor/in
  1. Sauter, Matthias |
  2. Weber, Lea |
  3. Jung, Dominik |
  4. Weremko, Michael |
  5. Bachmann, Dorothea |
  6. Fischereder, Michael |
  7. Bachmann, Hagen |
1000 Verlag BioMed Central
1000 Erscheinungsjahr 2024
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2024-03-08
1000 Erschienen in
1000 Quellenangabe
  • 19(1):106
1000 Copyrightjahr
  • 2024
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s13023-024-03118-9 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10921799/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • <jats:title>Abstract</jats:title><jats:p>Tuberous sclerosis complex (TSC) is a rare inherited disease with the potential to affect virtually every organ system. Clinical presentation is age- and partly sex-dependent and varies broadly with respect to disease manifestations including treatment-refractory epilepsy, intellectual disability and TSC-associated neuropsychiatric disorders, chronic kidney disease or progressive lung function decline. Given the complexity of this disease, multidisciplinary care in specialized TSC centres is recommended. We aimed to elucidate the state of knowledge of patients/caregivers and physicians on individual disease manifestations. We further examined whether the association to a TSC centre has an impact on the comprehensive consideration of potential disease manifestations. Therefore, a survey was performed in a cohort of German TSC patients and their physicians. Complete information was available for 94 patients with a median age of 18 years [range 1–55] and a sex distribution of 53.2% (male): 48.8% (female). Using almost identical questionnaires for patients/caregivers and their respective physician, there was a good correlation for disease assessments associated with relevant morbidity and mortality like epilepsy, renal angiomyolipoma, cardiac rhabdomyomas or intellectual disability. Correlation was moderate for several neuropsychiatric disorders and only poor for hypomelanotic macules, dental pits or retinal achromic patches. Estimation of overall disease severity using a numeric rating scale correlated highly significantly (Pearson correlation coefficient = 0.767; <jats:italic>p</jats:italic> &lt; 0.001) between patients/caregivers and physicians. In general, physicians more likely quoted items as ‘unknown’ than patients (822 answers vs. 435 answers in the respective groups). Questionnaires completed by physicians who were associated with a specialized TSC centre declared a significantly lower proportion of items as unknown (mean 8.7% vs. 20.5%; <jats:italic>p</jats:italic> &lt; 0.001). These findings indicate that patients treated by specialized TSC centres seem to obtain a more comprehensive surveillance. Furthermore, it shows that there were reasonable surveillance strategies in general and sufficient patient/caregiver interaction and education in the examined cohort. However, for the most prominent disease characteristics there was a good awareness within both the patients/caregivers and the physicians group.</jats:p>
1000 Sacherschließung
lokal Adolescent [MeSH]
lokal Female [MeSH]
lokal Physicians [MeSH]
lokal Tuberous Sclerosis/complications [MeSH]
lokal Adult [MeSH]
lokal Humans [MeSH]
lokal Angiomyolipoma/epidemiology [MeSH]
lokal Middle Aged [MeSH]
lokal Surveillance
lokal Kidney Neoplasms/complications [MeSH]
lokal Disease awareness
lokal Healthcare
lokal Infant [MeSH]
lokal Male [MeSH]
lokal Disease severity
lokal Patient Acuity [MeSH]
lokal Research
lokal Tuberous sclerosis complex
lokal Young Adult [MeSH]
lokal Intellectual Disability [MeSH]
lokal Child [MeSH]
lokal Child, Preschool [MeSH]
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/U2F1dGVyLCBNYXR0aGlhcw==|https://frl.publisso.de/adhoc/uri/V2ViZXIsIExlYQ==|https://frl.publisso.de/adhoc/uri/SnVuZywgRG9taW5paw==|https://frl.publisso.de/adhoc/uri/V2VyZW1rbywgTWljaGFlbA==|https://frl.publisso.de/adhoc/uri/QmFjaG1hbm4sIERvcm90aGVh|https://frl.publisso.de/adhoc/uri/RmlzY2hlcmVkZXIsIE1pY2hhZWw=|https://orcid.org/0000-0002-8642-540X
1000 Hinweis
  • DeepGreen-ID: 684c8abe45354a99973d273bc1dde68c ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Förderer
  1. Novartis Pharma |
  2. Private Universität Witten/Herdecke gGmbH |
1000 Fördernummer
  1. -
  2. -
1000 Förderprogramm
  1. -
  2. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Novartis Pharma |
    1000 Förderprogramm -
    1000 Fördernummer -
  2. 1000 joinedFunding-child
    1000 Förderer Private Universität Witten/Herdecke gGmbH |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6496520.rdf
1000 Erstellt am 2025-02-04T13:55:51.956+0100
1000 Erstellt von 322
1000 beschreibt frl:6496520
1000 Zuletzt bearbeitet 2025-08-05T07:28:31.015+0200
1000 Objekt bearb. Tue Aug 05 07:28:31 CEST 2025
1000 Vgl. frl:6496520
1000 Oai Id
  1. oai:frl.publisso.de:frl:6496520 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source